Abstract:BACKGROUND: Neuropathic pain (NP) is a common occurrence following spinal cord injury (SCI). Identification of specific molecular pathways that are involved in pain syndromes has become a major priority in current SCI research. We have investigated the role of a cation-dependent chloride transporter, Cl-regulatory protein Na(+)-K(+)-Cl(-) 1 (NKCC1), phosphorylation profile of NKCC1 and its specific involvement in neuropathic pain following contusion SCI (cSCI) using a rat model. Administration of the NKCC1 inhibitor bumetanide (BU) increases the mean hindpaw withdrawal latency time (WLT), thermal hyperalgesia (TH) following cSCI. These results demonstrate implication of NKCC1 co-transporter and BUin SCI-induced neuropathic pain. The with-no-lysine (K)-1 (WNK1) kinase has been shown to be an important regulator of NKCC1 phosphorylation in many systems, including nocioception. Mutations in a neuronal-specific exon of WNK1 (HSN2) was identified in patients that have hereditary sensory neuropathy type II (HSANII) also implicates WNK1 in nocioception, such that these patients have loss of perception to pain, touch and heat. In our ongoing research we proposed two studies utilizing our contusion SCI (cSCI) NP model of rat.PURPOSE: Study 1 aimed at NKCC1 expression and activity is up-regulated following cSCI in the early edema and chronic neuropathic pain phases. Study 2 aimed at identifying the expression profile of alternatively spliced WNK1 isoforms in animals exhibiting thermal hyperalgesia (TH) following cSCI.METHODS: Adult male Sprague Dawley rats (275-300 g) following laminectomy received cSCI at T9 with the NYU impactor-device II by dropping 10 g weight from the height of 12.5 mm. Control rats obtained laminectomy but no impaction. Following injury, functional recovery was assessed by BBB locomotor scores on day 1, 7, 14, 21, 35, and 42 and development of thermal hyperalgesia on day 21, 28, 35, and 42 day of injury by monitoring hind paw withdraw latency time (WLT) in seconds compared with the baseline data before injury.RESULTS: Increased NKCC1 may explain observed increase in magnetic resonance imaging (MRI) T2, exhibiting NKCC1 localization in neurons. This data supports NKCC1's role in the pathogenesis of acute and chronic phases of injury, namely spinal cord edema and chronic phase neuropathic pain. NKCC1 dependent chloride influx requires the phosphorylation at specific residues. Probing for the HSN2 exon of WNK1 reveals two key findings: i) the HSN2 exon is found in alternatively spliced neuronal isoforms found at 250 kDa and 230 kDa; ii) the 250 kDa isoform is found only in tissue that is injured.CONCLUSIONS: This data implicates the NKCC1/WNK1/WNK1HSN2 involvement in post-injury response that contributes to the development of neuropathic pain. Targeting this system may have therapeutic benefit.

Progress on the relationship between K+-Cl-cotransporter 2 and hyperalgesia

Potassium Chloride Cotransporter 2 Inhibits Neuropathic Pain and Future Development of Neurodegeneration.

BDNF modulated KCC2 ubiquitylation in spinal cord dorsal horn of mice

Expression Changes of K+–Cl− Co-Transporter 2 and Na+–K+–Cl− Co-Transporter1 in Mouse Trigeminal Subnucleus Caudalis Following Pulpal Inflammation

Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain.

Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats

The K + –cl − Cotransporter KCC2 and Chloride Homeostasis: Potential Therapeutic Target in Acute Central Nervous System Injury

Role of brain derived neurotrophic factor-tyrosinekinase receptor B-potassium-chloride cotransporter pathway in mechanisms of painful diabetic neuropathy in rats

Enhancing K-Cl co-transport restores normal spinothalamic sensory coding in a neuropathic pain model

Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K+-Cl- Cotransporter KCC2

Role of the potassium chloride cotransporter isoform 2-mediated spinal chloride homeostasis in a rat model of visceral hypersensitivity

Development of KCC2 therapeutics to treat neurological disorders

Research Progress of Mechanism of Potassium-Chloride Co-Transporter-2 Regulation

KCNQ2/3/5 Channels in Dorsal Root Ganglion Neurons Can Be Therapeutic Targets of Neuropathic Pain in Diabetic Rats

BDNF-TrkB Signaling Pathway-Mediated Microglial Activation Induces Neuronal KCC2 Downregulation Contributing to Dynamic Allodynia Following Spared Nerve Injury.

Kilohertz High-Frequency Electrical Stimulation Ameliorate Hyperalgesia by Modulating Transient Receptor Potential Vanilloid-1 and N-methyl-D-aspartate Receptor-2B Signaling Pathways in Chronic Constriction Injury of Sciatic Nerve Mice.

KCC2-GABAA Pathway Correlates with the Analgesic Effect of Electro-Acupuncture in CCI Rats

Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels

Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1

Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain

Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases